These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37389825)

  • 21. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis.
    Sagili KD; Muniyandi M; Shringarpure K; Singh K; Kirubakaran R; Rao R; Tonsing J; Sachdeva KS; Tharyan P
    Trop Med Int Health; 2022 Oct; 27(10):842-863. PubMed ID: 35927930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying gaps in the cascade of care for latent TB infection in a low-incidence setting.
    Grijota-Camino MD; Pérez-Recio S; Trapero C; Luque MJ; Casellas M; Sabé-Fernández N; Santin M
    Int J Tuberc Lung Dis; 2023 Apr; 27(4):315-321. PubMed ID: 37035981
    [No Abstract]   [Full Text] [Related]  

  • 23. Outcomes of latent tuberculosis infection treatment in Istanbul.
    Güner AE; Kiziltas S; Babalik A; Sahin E; Sibel A; Safak M; Kiliçaslan Z
    Int J Mycobacteriol; 2022; 11(4):442-447. PubMed ID: 36510932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of short course treatment for latent tuberculosis infection at a primary care facility for refugees in Winnipeg, Canada: A mixed methods evaluation.
    Chevrier C; Diaz MH; Rueda ZV; Balakumar S; Haworth-Brockman M; Marin DM; Oliver A; Plourde P; Keynan Y
    Front Public Health; 2022; 10():1064136. PubMed ID: 36726628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Latent tuberculosis screening and treatment among asylum seekers: a mixed-methods study.
    Spruijt I; Tesfay Haile D; Suurmond J; van den Hof S; Koenders M; Kouw P; van Noort N; Toumanian S; Cobelens F; Goosen S; Erkens C
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31537698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Latent Tuberculosis Care Cascade Among Public Health Clinics in the United States.
    Holzman SB; Perry A; Saleeb P; Pyan A; Keh C; Salcedo K; Narita M; Ahmed A; Miller TL; Pettit AC; Khurana R; Whipple M; Katz D; Largen A; Krueger A; Shah M;
    Clin Infect Dis; 2022 Nov; 75(10):1792-1799. PubMed ID: 35363249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries - a model-based cost-effectiveness analysis.
    Marx FM; Hauer B; Menzies NA; Haas W; Perumal N
    BMC Public Health; 2021 Nov; 21(1):2172. PubMed ID: 34836526
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
    Sharma SK; Sharma A; Kadhiravan T; Tharyan P
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD007545. PubMed ID: 23828580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.
    Lim R; Jarand J; Field SK; Fisher D
    Can Respir J; 2016; 2016():8249843. PubMed ID: 28127230
    [No Abstract]   [Full Text] [Related]  

  • 31. Determinants of losses in the latent tuberculosis cascade of care in Brazil: A retrospective cohort study.
    Araújo NCN; Cruz CMS; Arriaga MB; Cubillos-Angulo JM; Rocha MS; Silveira-Mattos PS; Matos GM; Marques IMB; Espirito Santo ICP; Almeida LL; Andrade CM; Souza LA; Netto EM; Andrade BB
    Int J Infect Dis; 2020 Apr; 93():277-283. PubMed ID: 32081776
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program.
    Wingate LT; Coleman MS; de la Motte Hurst C; Semple M; Zhou W; Cetron MS; Painter JA
    BMC Public Health; 2015 Dec; 15():1201. PubMed ID: 26627449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study.
    Winje BA; Grøneng GM; White RA; Akre P; Aavitsland P; Heldal E
    BMJ Open; 2019 Jan; 9(1):e023412. PubMed ID: 30782706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic review of latent tuberculosis infection research to inform programmatic management in Ireland.
    O'Connell J; de Barra E; McConkey S
    Ir J Med Sci; 2022 Aug; 191(4):1485-1504. PubMed ID: 34595689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
    Shamputa IC; Nguyen DTK; Higazy D; Abdelhadi A; MacKenzie H; Reddin M; Barker K; Webster D
    PLoS One; 2022; 17(11):e0277255. PubMed ID: 36331954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China.
    Xin H; Du Y; Cao X; Wang D; Zhang B; Zhang H; Feng B; He Y; He Y; Quan Z; Liu Z; Yan J; Guan L; Guan X; Shen F; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Dec; 10(6):e0296722. PubMed ID: 36445141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for prevalence of current TB disease and latent TB infection in type 2 diabetes mellitus patients attending a diabetic clinic in an Indian tertiary care hospital.
    Dabhi PA; Thangakunam B; Gupta R; James P; Thomas N; Naik D; Christopher DJ
    PLoS One; 2020; 15(6):e0233385. PubMed ID: 32502176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis, focussed tools and the right schools: estimated impact and cost of a targeted student screening programme for tuberculosis infection.
    Sawka A; Geake J; Stapledon R; Barry S
    Intern Med J; 2023 Jun; 53(6):978-984. PubMed ID: 35289041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spotlight on latent tuberculosis infection screening for juvenile idiopathic arthritis in two countries, comparing high and low risk patients.
    Piotto D; Nicacio A; Neto A; Mourão AF; Oliveira-Ramos F; Campanilho-Marques R; Guedes M; Cabral M; Santos MJ; Fonseca JE; Canhão H; Aikawa NE; Oliveira SKF; Ferriani VPL; Pileggi GCS; Magalhães CS; Silva CA; Terreri MT
    Adv Rheumatol; 2022 Jun; 62(1):20. PubMed ID: 35689240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening of health-care workers for latent tuberculosis infection in a Tertiary Care Hospital.
    Janagond AB; Ganesan V; Vijay Kumar GS; Ramesh A; Anand P; Mariappan M
    Int J Mycobacteriol; 2017; 6(3):253-257. PubMed ID: 28776523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.